Neumora Therapeutics

Neumora Therapeutics

  • Founded: 2020
  • Location: Watertown, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: Depression
  • Drug types: NEU, PSY
  • Lead product: NMRA-140
  • Product link: https://neumoratx.com/pipeline/
  • Funding: $112M B Oct 2022; $500M A Oct 2021
  • Investors: Abu Dhabi Growth Fund (ADG), Altitude Life Science Ventures, Amgen, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners


neumoratx.com

linkedin.com

job board


Short description:

Precision Medicines for Brain Diseases

Drug notes:

NMRA-511 Clin1 anxiety; NMRA-M4R Clin0 neuropsychiatric disorders; NMRA-GRIN2A Clin0 neuropsychiatric disorders; 3 programs RD/Clin0 neurodegenerative diseases

Long description:

Contact us to add description.

Jobs:

Neumora
Senior Manager, Clinical Operations
Watertown, MA|64 days ago
Apply
Neumora
Associate Director, Clinical Operations
Watertown, MA|64 days ago
Neumora
Director, SEC Reporting and Technical Accounting
Watertown, MA|64 days ago
Neumora
Senior Director, Clinical Operations
Watertown, MA|64 days ago
Neumora
Medical Director/Sr. Medical Director
Remote|80 days ago
Neumora
Vice President, CMC Management
Remote|100+ days ago
Neumora
Senior Manager, Regulatory Affairs
Remote|100+ days ago


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com